LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,649,952 | +1.5% | 352,091 | +4.3% | 0.14% | -0.7% |
| Q2 2023 | $23,296,590 | +73.2% | 337,485 | +21.0% | 0.14% | +75.6% |
| Q1 2023 | $13,450,583 | -40.6% | 278,942 | -38.5% | 0.08% | -33.9% |
| Q4 2022 | $22,644,860 | -10.1% | 453,623 | -26.5% | 0.12% | -3.1% |
| Q3 2022 | $25,188,000 | -19.9% | 617,350 | +8.0% | 0.13% | -3.8% |
| Q2 2022 | $31,437,000 | +59.3% | 571,587 | +5.2% | 0.13% | +66.2% |
| Q1 2022 | $19,740,000 | +264.6% | 543,206 | +367.6% | 0.08% | +158.1% |
| Q4 2021 | $5,414,000 | – | 116,159 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |